Loading...
XSHE
002223
Market cap3.89bUSD
Oct 09, Last price  
26.12CNY
1D
0.66%
1Q
0.38%
Jan 2017
26.31%
IPO
1,398.22%
Name

Jiangsu Yuyue Medical Equipment & Supply Co Ltd

Chart & performance

D1W1MN
XSHE:002223 chart
P/E
17.67
P/S
3.31
EPS
1.48
Div yield, %
3.08%
Shrs. gr., 5y
-0.09%
Rev. gr., 5y
3.28%
Revenues
7.90b
+4.47%
231,990,259289,481,810401,372,962537,881,597883,900,9771,162,178,7381,312,211,8761,424,323,3301,681,802,3022,103,737,2692,640,199,7933,541,562,7104,183,391,6224,635,934,6876,725,687,2896,894,308,1117,101,679,1597,971,734,4527,565,819,0177,903,651,427
Net income
1.48b
-17.94%
31,549,26937,872,71561,832,165100,542,425160,882,376226,411,771244,101,308258,053,467297,004,577364,343,530499,821,725592,029,453727,154,346752,567,2591,759,061,9661,482,421,6451,595,037,4372,395,853,2811,805,700,6591,481,794,880
CFO
1.56b
-14.16%
-16,572,45322,525,89660,600,14196,485,22065,661,70096,972,149171,419,700124,453,601205,781,087543,233,405676,978,914242,099,878798,144,562614,203,0422,830,851,0551,201,201,6332,304,919,4082,126,977,8411,816,269,7321,559,133,088
Dividend
Sep 01, 20260.4 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., formerly known as Yuwell Medical, was established in 1998 and is headquartered in Shanghai, China. The company operates globally, manufacturing and distributing a diverse array of medical devices in both domestic and international markets. Its extensive product catalog includes sophisticated respiratory therapy solutions, such as ventilators, humidifiers, oxygen generators, nebulizers, and advanced non-invasive ventilator data management systems. Yuwell also offers comprehensive chronic disease monitoring systems, featuring sphygmomanometers, blood glucose meters, pulse oximeters, thermometers, stethoscopes, alongside general practice diagnostic tools and in-hospital blood glucose management platforms. Furthermore, the company provides cutting-edge imaging diagnosis and treatment solutions, including ultrasound diagnostic imaging, interventional, and minimally invasive technologies. Its offerings extend to infection control and disinfection products, as well as specialized ophthalmology and vision care items like microscopes, eye surgical instruments, ophthalmoscopes, synoptophores, and keratometers. Defibrillator monitors are also part of their product range. Additionally, Yuwell supplies a broad spectrum of durable medical equipment and consumables, encompassing basic and microsurgical tools, instruments for ENT and orthopedics, endoscopic devices, dental appliances, acupuncture and electronic acupuncture products, absorbable sutures, and venous indwelling needles.

Key people

Yong Zhang
Chief Financial Officer, Deputy General Manager · since 2021
Lihua Wang
President of Medical Health Business Group, Director · since 2020
Lihua Liu
Finance Director, Chief Accounting Officer · since 2021
Qun Wu
Chairman of the Board, General Manager · since 2020
Guomin Jing
Deputy General Manager · since 2020
Wei Jing
Deputy General Manager · since 2021
Jianqiang Mao
Deputy General Manager · since 2009
Nanxuan Xu
Deputy General Manager · since 2020
Caihao Yu
Deputy General Manager · since 2025
Shuai Zhao
Deputy General Manager, Director · since 2020
Ruijie Wang
Secretary of the Board, Director · since 2020
Jianjun Chen
Director · since 2020
Hongzhe Zheng
Deputy General Manager, Director · since 2024
Suiren Wan
Independent Director · since 2020
Chun Yu
Independent Director · since 2020
Mingxia Zhong
Independent Director · since 2022
IPO date
Apr 18, 2008
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
丹阳市 开发区 百胜路1号
镇江市, JS 212300
CN
Address
No.1 Baisheng Road, Development Zone Danyang
Zhengjiang, JS 212300
CN
Other language
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT